Breaking News: VSTM – Market Insights, Analysis & Latest Updates

VSTM

Verastem director sells shares worth $365 to meet tax obligations

Robert E. Gagnon sold shares of Verastem, Inc. to cover taxes, while the company's stock targets were revised. Verastem focuses on cancer treatments and is following promising research.

investing.com • 20/09/2024 - 22:05 PM

VSTM

Verastem CEO sells shares worth $513 to cover tax obligations

Dan Paterson, CEO of Verastem, sold shares to meet tax obligations, while the company also announced stock offering and received FDA designation for cancer treatment.

investing.com • 20/09/2024 - 22:03 PM

VSTM

Verastem director Brian Stuglik sells shares worth $937

Verastem, Inc. reports insider share sale, financial analyses, and liquidity strengths, while facing challenges in profitability and stock price adjustments from financial firms.

investing.com • 20/09/2024 - 22:03 PM

Greed and Fear Index

Note: The data is for reference only.

Greed

Verastem director sells shares worth $365 to meet tax obligations

Verastem CEO sells shares worth $513 to cover tax obligations

Verastem director Brian Stuglik sells shares worth $937

Currency